ImmunoGen misses by $0.02, beats on revenue

• ImmunoGen (NASDAQ:IMGN): FQ2 EPS of -$0.38 misses by $0.02.
• Revenue of $18.03M (-62.7% Y/Y) beats by $0.16M.
• Press Release